India, Nov. 6 -- Food Innovation Solutions' (FIS) UK-based Appetite Shift study has identified five emerging trends linked to the growing use of GLP-1 medications, highlighting new product development opportunities for food and beverage manufacturers. The findings indicate that GLP-1 use is influencing not only consumers' food choices but also their eating habits, nutritional priorities and expectations around taste and product formats.

The three-wave study, conducted between August 2025 and March 2026, surveyed 1,200 UK adults, including a nationally representative sample of 1,000 consumers and an additional sample of GLP-1 users. The research was sponsored in part by Givaudan.

According to the findings, five key trends are emerging: p...